Global Regulatory Affairs Outsourcing Services Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Regulatory Affairs Outsourcing Services Market Research Report 2024
Regulatory affairs (RA), also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, agrochemicals (plant protection products and fertilizers), energy, banking, telecom etc.
According to MRAResearch’s new survey, global Regulatory Affairs Outsourcing Services market is projected to reach US$ 7167.3 million in 2033, increasing from US$ 4273.6 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Regulatory Affairs Outsourcing Services market research.
Key companies engaged in the Regulatory Affairs Outsourcing Services industry include Medpace Inc., Accell Clinical Research, PRA International, Criterium Inc., PAREXEL International Corporation, Clinilabs Inc., Quintiles Transnational Holdings and Charles River Laboratories International Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Regulatory Affairs Outsourcing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Regulatory Affairs Outsourcing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Regulatory Affairs Outsourcing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Medpace Inc.
Accell Clinical Research
PRA International
Criterium Inc.
PAREXEL International Corporation
Clinilabs Inc.
Quintiles Transnational Holdings
Charles River Laboratories International Inc.
Segment by Type
Regulatory Writing & Publishing
Regulatory Consulting
Clinical Trial and Product Registration
Legal Representation
Other Services
Pharma Industry
Biotech Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Regulatory Affairs Outsourcing Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Regulatory Affairs Outsourcing Services market is projected to reach US$ 7167.3 million in 2033, increasing from US$ 4273.6 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Regulatory Affairs Outsourcing Services market research.
Key companies engaged in the Regulatory Affairs Outsourcing Services industry include Medpace Inc., Accell Clinical Research, PRA International, Criterium Inc., PAREXEL International Corporation, Clinilabs Inc., Quintiles Transnational Holdings and Charles River Laboratories International Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Regulatory Affairs Outsourcing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Regulatory Affairs Outsourcing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Regulatory Affairs Outsourcing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medpace Inc.
Accell Clinical Research
PRA International
Criterium Inc.
PAREXEL International Corporation
Clinilabs Inc.
Quintiles Transnational Holdings
Charles River Laboratories International Inc.
Segment by Type
Regulatory Writing & Publishing
Regulatory Consulting
Clinical Trial and Product Registration
Legal Representation
Other Services
Segment by Application
Pharma Industry
Biotech Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Regulatory Affairs Outsourcing Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source